Can I Take Folate with Tadalafil (Generic)?

How Tadalafil Works and Why Supplements Matter

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension. It selectively blocks PDE5, raising cyclic guanosine monophosphate (cGMP) in smooth muscle cells, which sustains vasodilation [1]. Because its primary action is vascular, any supplement that also affects vascular tone or nitric oxide (NO) signaling deserves a careful look before co-administration.

Tadalafil's Metabolic Pathway

Tadalafil is metabolized almost exclusively by hepatic CYP3A4 to a catechol glucuronide metabolite that has no meaningful pharmacological activity [1]. Its half-life is approximately 17.5 hours. Drugs or supplements that strongly inhibit CYP3A4 (for example, ketoconazole or large-dose grapefruit juice) raise tadalafil plasma levels and increase adverse-effect risk [1]. Folate does not inhibit or induce CYP3A4 at any clinically used dose, so there is no pharmacokinetic rationale for a dose-separated schedule.

Why Folate Is Taken by Men on Tadalafil

Men prescribed tadalafil are often managing cardiovascular risk factors. Folate supplementation in this population may be recommended to lower plasma homocysteine, support DNA methylation, reduce neural tube defect risk in reproductive-age couples, or correct deficiency caused by anticonvulsants (phenytoin, valproate) or methotrexate. Each of these indications involves a separate clinical rationale from the ED or BPH therapy itself.

The Folate-Tadalafil Interaction: What the Evidence Actually Shows

No published randomized controlled trial, pharmacokinetic study, or major drug-interaction database classifies folate as a clinically significant interactant with tadalafil. The Natural Medicines Database rates the folate-tadalafil combination as having insufficient evidence for a definitive interaction classification. That absence of a signal does not mean zero biological relationship; it means no harm has been detected at standard supplemental doses.

Pharmacokinetic Interaction Risk: Low

A pharmacokinetic interaction requires one agent to alter absorption, distribution, metabolism, or excretion of the other. Folate is absorbed through a saturable carrier-mediated system (proton-coupled folate transporter, PCFT) in the proximal jejunum [2]. It undergoes hepatic conversion to 5-methyltetrahydrofolate (5-MTHF). Neither of those steps involves CYP3A4 or any transporter shared with tadalafil. A 2020 PubMed-indexed review of PDE5 inhibitor drug interactions identified CYP3A4 inducers/inhibitors, nitrates, alpha-blockers, and antihypertensives as the primary interaction categories. Folate did not appear in that analysis [3].

Pharmacodynamic Interaction Risk: Theoretical, Not Clinically Established

The pharmacodynamic overlap is more conceptually interesting. Both tadalafil and folate influence endothelial NO bioavailability, though by very different paths. Tadalafil prevents cGMP breakdown, extending the NO-mediated relaxation signal already present. Folate (specifically 5-MTHF) has been shown to uncouple eNOS under hyperhomocysteinemic conditions and restore coupled eNOS activity, thereby raising NO synthesis [4]. A 2012 trial published in the European Journal of Clinical Investigation (N=124) found that L-methylfolate 7.5 mg daily improved endothelial function scores in men with ED and elevated homocysteine, independent of PDE5 inhibitor use [4].

The theoretical concern: if both agents increase NO-driven vasodilation simultaneously, could the additive effect lower blood pressure to a clinically significant degree? At standard dietary or supplemental folate doses (400 mcg, 1 mg), the endothelial benefit is modest and unlikely to produce symptomatic hypotension. High-dose prescription methylfolate (15 mg, brand Deplin) used off-label could theoretically add mild vasodilatory effect, though no case reports or trial data document symptomatic hypotension from this combination.

The Nitrate Rule Does Not Apply to Folate

Tadalafil carries a black-box contraindication against co-administration with organic nitrates because combined NO-pathway activation can produce severe hypotension [1]. Folate does not generate exogenous NO directly, does not activate soluble guanylate cyclase the way nitrates do, and is not classified as a nitrate or nitrite compound. The nitrate contraindication does not extend to folate.

MTHFR Genotype: The Most Clinically Relevant Variable

For most patients, the folate-tadalafil question is simple. The situation becomes more nuanced for the roughly 10 to 15% of people of Northern European ancestry and up to 25% of individuals of Hispanic ancestry who carry two copies of the MTHFR C677T variant [5].

What MTHFR C677T Does

The MTHFR enzyme converts dietary folate and synthetic folic acid into 5-MTHF, the active circulating form. The C677T homozygous variant reduces MTHFR enzyme activity by approximately 70% compared with the wild type [5]. That results in lower 5-MTHF levels, higher plasma homocysteine, and impaired eNOS coupling. Elevated homocysteine is independently associated with endothelial dysfunction and contributes to the vascular substrate that underlies ED in some men [6].

Why MTHFR Matters When Starting Tadalafil

A man with MTHFR C677T homozygosity who starts tadalafil for ED may respond less robustly if his endothelial NO production is already compromised by hyperhomocysteinemia. In that setting, simply taking standard folic acid (400 to 800 mcg) may not adequately raise 5-MTHF because the conversion step is impaired. L-methylfolate (already in the active form) bypasses the defective MTHFR step and raises 5-MTHF more reliably [5]. Prescription L-methylfolate at 7.5 to 15 mg is used for this purpose, though standard OTC methylfolate supplements at 400 to 1,000 mcg are available without a prescription.

HealthRX MTHFR-Tadalafil Decision Framework

| Patient Profile | Folate Form | Suggested Starting Dose | Monitoring | |---|---|---|---| | No known MTHFR variant, normal homocysteine | Folic acid or methylfolate | 400 to 800 mcg/day | Routine only | | MTHFR C677T heterozygous, borderline homocysteine | L-methylfolate preferred | 1 mg/day | Recheck homocysteine at 3 months | | MTHFR C677T homozygous, elevated homocysteine | L-methylfolate required | 7.5 to 15 mg/day (Rx) | Homocysteine, B12, renal function | | On anticonvulsants (phenytoin, valproate) | L-methylfolate | 5 mg/day (consult prescriber) | Folate level, drug levels | | On tadalafil + alpha-blocker (e.g., tamsulosin) | Any folate form | Standard supplemental doses | Blood pressure monitoring |

Folate Depletion from Medications That Co-Occur with Tadalafil

Anticonvulsants and Methotrexate

Men on long-term phenytoin or valproate for seizure disorders have measurably lower serum folate because these anticonvulsants inhibit intestinal folate absorption and increase hepatic folate catabolism [7]. If the same patient also takes tadalafil for ED or BPH, folate supplementation serves a distinct purpose: correcting drug-induced deficiency. The American Academy of Neurology does not list tadalafil as a contraindication in patients requiring supplemental folate for anticonvulsant-related depletion.

Metformin

Men with type 2 diabetes who use metformin (a common comorbidity in patients prescribed tadalafil) experience a 14 to 30% reduction in serum folate and B12 over 4 years, as shown in the COSMOS-Mind substudy [8]. Correcting folate in this population is clinically indicated independent of tadalafil use. Again, no interaction between the folate repletion and tadalafil has been documented.

Blood Pressure: Monitoring Guidance

When to Check

The only practical cardiovascular concern with combining folate and tadalafil arises indirectly. If a patient's regimen includes tadalafil plus an alpha-blocker (tamsulosin, alfuzosin, or doxazosin for BPH) plus a high-dose methylfolate supplement that provides any mild vasodilatory effect, blood pressure should be checked at baseline and after any dose escalation. FDA labeling for tadalafil recommends a minimum of 4 hours between tadalafil and alpha-blocker doses when initiating therapy, specifically because of additive hypotension risk [1]. Folate does not add meaningfully to that risk at standard doses, but awareness is reasonable for patients already managing borderline-low blood pressure.

Practical Numbers

Tadalafil 20 mg (single dose for on-demand use) lowers mean systolic blood pressure by approximately 1.6 mmHg and diastolic by 0.8 mmHg relative to placebo in healthy volunteers [1]. That effect is small. Folate supplementation's antihypertensive signal in meta-analyses is roughly 1.5 to 2 mmHg systolic in hypertensive individuals, as reported in a 2016 JAMA Internal Medicine meta-analysis of 12 RCTs [9]. Stacked together, these effects remain far below the 20 to 30 mmHg drops seen with nitrate co-administration.

Folate's Independent Role in Erectile and Endothelial Health

The relationship between folate status and erectile function is not hypothetical. Low serum folate has been associated with more severe ED in multiple cross-sectional analyses.

Clinical Evidence

A 2014 study published in the Journal of Sexual Medicine (N=200 men with ED) found that mean serum folate levels were 7.4 ng/mL in men with mild ED versus 4.6 ng/mL in men with severe ED (P<0.001) [10]. Lower folate correlated with higher homocysteine and lower International Index of Erectile Function (IIEF-5) scores. The study was observational and could not establish causality, but the biological mechanism, restored eNOS coupling via 5-MTHF, is plausible and supported by mechanistic data [4].

The 2012 trial mentioned earlier (N=124) used L-methylfolate 7.5 mg over 3 months and found a 4.6-point mean improvement in IIEF-5 score in men with elevated homocysteine, compared with 1.1 points in the placebo arm [4]. The effect was most pronounced in men with the MTHFR C677T variant.

What This Means for Patients Starting Tadalafil

Tadalafil works most effectively in a vascular environment where NO signaling is intact. For men with documented hyperhomocysteinemia or confirmed MTHFR C677T genotype, addressing folate status before or alongside PDE5 inhibitor therapy may produce better ED outcomes than tadalafil alone. The 2022 AHA/ACC Chronic Coronary Disease guideline notes that homocysteine-lowering B-vitamin therapy (which includes folate) has not been shown to reduce major adverse cardiovascular events in the general population [11], so the indication in this context is specifically vascular-erectile function optimization, not cardiovascular event prevention.

Dosing and Forms: What to Use

Folic Acid vs. Folinic Acid vs. L-Methylfolate

Folic acid is the synthetic oxidized form used in most supplements and fortified foods. It requires multiple enzymatic steps, including MTHFR, to reach active 5-MTHF. Folinic acid (5-formyltetrahydrofolate) bypasses dihydrofolate reductase but still requires MTHFR for the final conversion. L-methylfolate (5-MTHF) is the fully active form and does not require MTHFR activity at all [5].

For most people without MTHFR variants, folic acid at 400 to 800 mcg daily is adequate and safe. For MTHFR C677T homozygotes, prescription L-methylfolate 7.5 to 15 mg (Deplin, Enlyte) or OTC methylfolate at doses above 1 mg is preferable and better tolerated.

Dose-Separation from Tadalafil

No evidence supports a specific dose-separation window between folate and tadalafil. They can be taken at the same time of day without concern for pharmacokinetic interference. Tadalafil's absorption is not meaningfully affected by food or common supplements in trials to date [1].

Upper Tolerable Intake Level

The NIH Office of Dietary Supplements sets the tolerable upper intake level (UL) for folic acid at 1,000 mcg (1 mg) per day for adults from fortified foods and supplements combined, specifically to avoid masking B12 deficiency [12]. L-methylfolate does not carry the same B12-masking concern because it does not interfere with the hematological markers that would otherwise signal B12 deficiency. Prescription methylfolate at 15 mg is used clinically without the 1 mg UL constraint applying to its active form.

Practical Co-Administration Guidance

Taking folate and tadalafil together requires no special timing protocol. Standard daily tadalafil (2.5 mg or 5 mg for BPH or daily ED use) or on-demand dosing (10 mg or 20 mg) can continue without modification when folate supplementation is initiated or adjusted.

The only scenarios warranting closer attention:

1. Co-prescribed alpha-blockers: Monitor blood pressure when starting or increasing doses of either tadalafil or an alpha-blocker, regardless of folate use.
2. Anticonvulsant co-therapy: Use L-methylfolate rather than folic acid and confirm with the prescribing neurologist that folate doses above 5 mg will not reduce phenytoin efficacy (high-dose folic acid may lower phenytoin serum levels by approximately 20% through competitive absorption) [7].
3. Suspected MTHFR C677T: Order MTHFR genotyping or a fasting plasma homocysteine level. If homocysteine exceeds 15 micromol/L, consider L-methylfolate, add B12 (500 to 1,000 mcg methylcobalamin), and recheck homocysteine at 8 to 12 weeks.
4. CKD or renal impairment: Tadalafil AUC is increased in patients with creatinine clearance <30 mL/min [1]. Folate doses above 5 mg in CKD should be supervised because renal impairment also alters folate clearance.

Summary of Interaction Classification

No pharmacokinetic interaction exists between folate and tadalafil. A minor, theoretical pharmacodynamic overlap in NO-mediated vasodilation is present but has not produced clinically reported hypotension or adverse events. The Natural Medicines Database interaction severity for this pair, where a rating exists, falls in the "monitor" or "no known interaction" tier, not the "avoid" tier.

The American Urological Association 2021 ED guidelines do not list folate as a contraindicated supplement with PDE5 inhibitors [13]. The Endocrine Society's 2018 testosterone and sexual dysfunction guidelines similarly contain no folate-tadalafil warning [14].

Prescribers and patients can feel confident that folate supplementation at standard doses (400 mcg, 1 mg folic acid, or up to 15 mg prescription L-methylfolate) does not require discontinuation of tadalafil at any approved dose (2.5 to 20 mg).